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Abstract
Pigs are the natural host for Chlamydia suis, a pathogen which is phylogenetically highly related to the human pathogen C.
trachomatis. Chlamydia suis infections are generally treated with tetracyclines. In 1998, tetracyline resistant C. suis strains
emerged on U.S. pig farms and they are currently present in the Belgian, Cypriote, German, Israeli, Italian and Swiss pig
industry. Infections with tetracycline resistant C. suis strains are mainly associated with severe reproductive failure leading to
marked economical loss. We developed a sensitive and specific TaqMan probe-based C. suis real-time PCR for examining
clinical samples of both pigs and humans. The analytical sensitivity of the real-time PCR is 10 rDNA copies/reaction without
cross-amplifying DNA of other Chlamydia species. The PCR was successfully validated using conjunctival, pharyngeal and
stool samples of slaughterhouse employees, as well as porcine samples from two farms with evidence of reproductive
failure and one farm without clinical disease. Chlamydia suis was only detected in diseased pigs and in the eyes of humans.
Positive humans had no clinical complaints. PCR results were confirmed by culture in McCoy cells. In addition, Chlamydia
suis isolates were also examined by the tet(C) PCR, designed for demonstrating the tetracycline resistance gene tet(C). The
tet(C) gene was only present in porcine C. suis isolates.
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Introduction
Chlamydiaceae are obligate intracellular Gram-negative bacteria
that cause a broad range of diseases in both humans and animals.
Pigs can become infected by Chlamydia (C.) pecorum, C. abortus, C.
psittaci and C. suis [1]. Seroprevalence rates of Chlamydiaceae in
German, Swiss, Italian and Belgian pigs are high (40–96%)
[2,3,4,5]. As far as known, the pig is the only host for C. suis, which
is phylogenetically closely related to the human pathogenic agent
C. trachomatis [1]. Chlamydia suis infections can be asymptomatic or
associated with arthritis, pericarditis, polyserositis, pneumonia,
conjunctivitis, enteritis, diarrhea and reproductive failure
[4,6,7,8,9,10]. Experimental infections in specific pathogen free
and gnotobiotic pigs using C. suis field strains have resulted in
conjunctivitis, respiratory lesions and gastrointestinal lesions
[11,12,13]. To date, transmission of C. suis to humans has not
been reported [14]. However, C. suis and C. trachomatis are closely
related [1] and, therefore, the zoonotic potential of C. suis is likely.
Chlamydia suis can be difficult to grow in cell culture or
embryonated eggs [14]. A molecular diagnostic test, able to
specifically detect C. suis in both animal and human samples, is
crucial to gain insights into the prevalence, the economic impact
and the zoonotic ‘threat’ of C. suis infections. In 2006, Sachse et al.
[15], developed a 23S rDNA gene-based array tube (AT) micro
array for detection and differentiation of Chlamydia spp. The assay
detects a single copy of the cloned target DNA [16]. Borel et al.
[17] calculated the sensitivity of the AT micro array over an entire
panel of human and animal clinical samples, including five human
pharyngeal swabs and four tissues of naturally infected diseased
pigs. The sensitivity of the AT micro array was slightly lower than
for real-time PCR. When excluding long-time stored swab samples
from the calculation, the sensitivity was equivalent to that of real-
time PCR. However, in our hands, C. suis species identification by
use of the AT microarray was often only possible on isolates of
vaginal and rectal swabs and not directly on these clinical samples
[18]. More recently, Pantchev et al., [19] developed a 23S rDNA
gene-based real-time PCR for C. suis. However, the PCR was
strictly developed for the examination of veterinary samples as it
cannot distinguish C. suis from the genetically closely related
human pathogen C. trachomatis [19]. Therefore, it was the aim of
the present study to develop a sensitive and specific C. suis real-
time PCR for the purpose of examining clinical samples of both
pigs and humans.
Materials and Methods
1. Bacterial cultures
For determination of sensitivity, specificity and detection limit of
the C. suis-specific real-time PCR, the following 14 chlamydial
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strains were used: C. suis strains S45, R19, H7, R24, R27 and R33,
C. pneumoniae (TW-183), C. felis (FP Baker), C. caviae (GIPC), C.
abortus (S26/3), C. psittaci (92/1293), C. pecorum (1710S), C.
muridarum (MoPn) and C. trachomatis (L2/434/BU). Bacteria were
grown in cycloheximide treated McCoy cells (mouse fibroblast
cells, obtained from Els De Coster, Labo Medische Analyse, CRI,
Zwijnaarde, Belgium; original source: ATCC CRL-1696) using a
standard methodology, as described previously [20]. Chlamydiae
were released from infected monolayers (two passages) by freezing
and thawing, followed by ultrasonication (Bransonic 12, BIOME-
Device, San Pablo, CA, USA). Cell culture harvest was centrifuged
for 10 min (1000 6 g, 4uC) and Chlamydiae were subsequently
concentrated by ultracentrifugation for 45 minutes (50,000 6 g,
4uC). Bacteria were resuspended in 2 mL sucrose phosphate
glutamate buffer (SPG, 218 mM sucrose, 38 mM KH2PO4,
7 mM K2HPO4, 5 mM L-glutamic acid) and stored at –80uC
until use.
2. DNA extraction
Genomic DNA of bacterial cultures was prepared using the
DNeasy Blood and Tissue Kit (Qiagen, Antwerp, Belgium). DNA
extraction of clinical samples was performed using the G-spin
Total DNA Extraction Mini Kit (Goffin Molecular Biotechnolo-
gies, Beek, The Netherlands). Both extraction methods were
performed according to the instructions of the manufacturers.
3. Primers and probes
Published 23S ribosomal RNA sequences of all known
chlamydial species (Table 1) [1] were aligned using Clustal X
software (default settings) [21]. Forward and reverse primers (Life
technologies, Paisley, United Kingdom) and probes (Eurogentec,
Seraing, Lie`ge, Belgium) were designed using primer3 software
(Table 2) [22]. Primer and probe specificity was checked by
BLAST [21]. The optimal annealing temperature and specificity
of the primers and probes within the genome was evaluated in
20 ml PCR reactions containing 3 ml of 2 mM of forward and
reverse primers, 0.5 ml Super Taq 5U/ml (Sphaero Q, Gorinchem,
The Netherlands), 2 ml Super Taq Reaction Buffer, 2 ml of each of
1.25 mM dNTP and 50 ng of genomic DNA of C. suis strain S45.
The cycling conditions were as follows: 72uC for 5 minutes; 35
cycles of 95uC for 60s, 60uC for 60s and 72uC for 60s and a final
step of 72uC for 5 min. CS23S-probe A and B were 59 labeled with
the reporter dye 6-carboxyfluorescein (FAM) and hexachloro-
fluoresceine (HEX) respectively, and 39 labeled with the quencher
dye carboxytetramethylrhodamine (TAMRA).
4. Inhibition control plasmid
The 23S rDNA amplicon of C. suis (S45) was amplified using
20 ml PCR reactions containing 3 ml of 2 mM of forward and
reverse primers, 0.5 ml Super Taq 5U/ml (Sphaero Q, Gorinchem,
The Netherlands), 2 ml Super Taq Reaction Buffer, 2 ml of each of
1.25 mM dNTP and 50 ng of genomic DNA. PCR products were
purified using the Wizard SV Gel and PCR Clean-Up System
(Promega, Madison, WI, USA) and cloned into pGem-T
(Promega, Madison, WI, USA) according to the manufacturer’s
protocol. To verify the nucleotide sequence of the inserted
fragment, sequence analyses were performed by the VIB Genetic
Service Facility (University of Antwerp, Antwerp, Belgium) using
vector associated T7 and SP6 priming sites. The resulting C. suis-
species-specific internal inhibition control plasmid was designated
pGemT::CSIC.
5. Species-specific real-time PCR
Real-time PCR was performed with the Rotor-Gene Q
Instrument (Qiagen Benelux, Venlo, The Netherlands) using
25 ml reaction mixture containing 2 ml of DNA template, 4 ml of
primer mixture (300 nM forward and reverse primer), 2.5 ml of
CS23S-probe A and B (200 nM), 12.5 ml of absolute qPCR mix
(Thermoscientific, Acros Organics, Geel, Belgium) and 1.5 ml
DNAse and RNAse free water. The cycling conditions were as
follows: 95uC for 15 minutes, 50 cycles of 95uC for 15 seconds,
60uC for 60 seconds. All default program settings were used.
Standard graphs of the Cycle threshold (Ct) values, obtained by
testing tenfold serial dilutions (108 to 101) of the purified species-
specific inhibition control plasmid, were used for quantification.
DNA was always tested in the presence of control plasmid (50
copies/ml) to check for PCR inhibitors.
6. Analytical sensitivity and specificity
The analytical sensitivity of the assay was evaluated using
decimal serial dilutions (108 to 101 copies/ml) of the inhibition
control plasmid and of purified genomic DNA of the C. suis
reference strain S45 from suspensions equivalent to 108 to 101
copies/ml. Three independent dilution series were analyzed and
reactions were performed in triplicate. The specificity was
evaluated using: i) genomic DNA from C. peumoniae (TWAR), C.
felis (FP Baker), C. caviae (GPIC), C. abortus(S26/3), C. psittaci (92/
1293), C. pecorum (1710S), C. muridarum (MoPn) and C. trachomatis
(L2/434/BU) as well as ii) DNA from 23 and 38 bacterial species
commonly found in swine and humans, respectively, and iii)
genomic DNA from swine and human tissues (Table 3 and 4).
7. Case studies
7.1. Pig farms. To validate the performance of the C. suis
real-time PCR, vaginal swabs originating of 10 to 15 sows from
three Dutch pig (A, B, C) farms were tested. Two of the three
farms were dealing with cases of reproductive failure (decrease of
the conception rate from 90 to ,65%, 1–3% abortions, sows that
delivered only two to five piglets of a non-uniform weight, white to
yellow non-smelling vulval liquid, irregular return to estrus).
Clinical disease did not improve following medication with
doxycycline [400 g (ton feed) 21] plus a combination of
trimethoprim [120 g (ton feed) 21] and sulfamethoxazole [600 g
(ton feed) 21] for 10–14 days during gestation and half of these
drug concentrations during lactation. Antibody detection or PCR
for Leptospira species, Mycoplasma species, Brucella suis, porcine
reproductive and respiratory syndrome virus, Aujeszky’s disease,
swine influenza, porcine circovirus 2 and porcine parvovirus, were
negative. Tests were performed at the Dutch Animal Health
Service (Deventer, The Netherlands) and by the Flemish Animal
Health Service (Drongen, Belgium). The third farm reported no
clinical problems and was included as a negative control.
Animals were sampled for C. suis culture and PCR. For culture,
rayon-tipped aluminium-shafted swabs (Copan; Fiers, Kuurne,
Belgium) were immersed in chlamydia transport medium [20]
immediately after vaginal sampling and stored at 280uC for
culture. For PCR, vaginal swabs immersed in DNA/RNA
stabilization buffer (Roche) were stored at 280uC. All DNA
extractions were performed using the G-spin Total DNA
Extraction Mini Kit (Goffin Molecular Biotechnologies, Beek,
The Netherlands) according to the manufacturer’s protocol.
Purified DNA of vaginal swabs was analyzed by the newly
developed C. suis-specific real-time PCR. Presence of viable
Chlamydiae was determined by inoculation on McCoy cells (in
duplicate) followed by direct immunofluorescence (anti-LPS/
FITC) staining on the first culture drum at six days post
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inoculation (Imagen, Oxoid, Drongen, Belgium). If positive, the
second culture drum was used for C. suis identification by use of
the newly developed real-time PCR. Positively identified C. suis
isolates were also examined by the tet(C) PCR, designed for
demonstrating the tetracycline resistance gene tet(C) [23], For this
purpose, we used genomic DNA of the TcR C. suis strain R19 [24]
as positive control.
All animal samples were received from veterinary practitioners
and were delivered for diagnostic purpose. Therefore, approval of
the veterinary ethical committee was not required.
7.2. Slaughterhouse employees. Validation of the C. suis
PCR for human diagnosis was performed by sampling abattoir
workers. During a yearly medical check up, employees of a Belgian
pig slaughterhouse were asked (informed consent) to voluntarily
provide a pharyngeal and conjunctival swab, as well as a swab of
fresh stool. Rayon-tipped aluminium-shafted swabs were im-
mersed in chlamydia transport medium [20] and stored at 280uC
until culture. Swabs for PCR were immersed in DNA/RNA
stabilization buffer and stored at 280uC. Purified DNA was
analyzed by the newly developed C. suis-specific real-time PCR.
Presence of viable Chlamydiae, identification of viable C. suis and the
presence of the tet(C) gene in C. suis strains was examined as
mentioned for the pig farms.
The case study was approved by the medical ethical committee
(approval EC UZG 2011/459). Participants provided their written
informed consent and the consent procedure was approved by the
medical ethical committee of Ghent University.
Results
1. Primers and probes
It was impossible to design C.usuis-specific primers in the 23S
rDNA target region, such that the forward and reverse primers
would also not anneal to C.utrachomatis DNA. However, we were
able to design C. suis-specific probes for real-time PCR. The
differentially labeled probes CS23S-A and CS23S-B were C. suis-
specific and they were both required for coverage of the selected
target region of all known C. suis strains (Table 2). Forward
(CS23S-F) and reverse (CS23S-R) primers generated a PCR
product of 159 bp.
2. Internal inhibition control
Standard curves made using 106 to 101 copies of the
pGemT::CSIC control plasmid (Figure 1) showed slopes around
23.103, which correlates to an efficiency of 109%, with
correlation coefficients . 98%.
3. Species-specific real-time PCR
The species-specific real-time PCR detected all known C. suis
strains. Amplification of genomic DNA extracts of all C. suis strains
resulted in the expected PCR products with amplification curves
exceeding the 0.02 threshold before cycle 25. The species-specific
PCR was able to detect 10 rDNA copies (or two copies/ml) of both
genomic and control plasmid DNA. Standard curves resulting
from the sensitivity analysis are shown in Figure 1. The slopes were
around 23.5, which correlates to an efficiency of 91%, with
correlation coefficients . 99%. The species-specificity test
Table 1. NCBI Nucleotide Accession numbers of the 23S rRNA gene sequences that were used for the alignment to design the
primers and C. suis specific probes.
Species Strain NCBI Nucleotide Accession Number
Chlamydia suis R22 U68420
Chlamydia trachomatis L2/434/BU U68443
Chlamydia abortus EBA U76710
Chlamydia psittaci NJ1 U68419
6BC U68447
Chlamydia pecorum IPA U68434
Chlamydia felis FP Baker U68457
Chlamydia muridarum MoPn U68436
SFPD U68437
Chlamydia caviae GPIC U68451
Chlamydia pneumoniae TW-183 U76711
doi:10.1371/journal.pone.0096704.t001
Table 2. Primers and probes of the C. suis specific real-time PCR.
Oligonoculeotide Sequence (59- 39) Positiona Specificity
CS23S-F GCAGAGGAAAAGAAATCGAAGA 215–236 C. suis and C. trachomatis
CS23S-R CGGGACTATCACCCTGTATC 359–378 C. suis and C. trachomatis
CS23S-ProbeA FAM-CGAGCTGAAGAAGCGAGGGGTTGTAG-TAMRA 280–305 C. suis
CS23S-ProbeB HEX-CGAGCCGAAGAAGCGAGGGGTTGTAG-TAMRA 280–305 C. suis
aBinding position from base 1 of the 23S rRNA gene of the chlamydial reference strain S45.
doi:10.1371/journal.pone.0096704.t002
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revealed a Ct-value of 19 for DNA of 106 TCID50 C. suis. Real-
time PCR on genomic DNA of C. pneumoniae, C. felis, C. caviae, C.
pecorum, C. abortus, C. muridarum and C. trachomatis generated no
signal. The real-time PCR gave no results for genomic DNA of
other pathogens commonly found in the eyes, respiratory or
urogenital tract of swine and humans, neither with DNA from
swine or human tissues.
4. Case studies
4.1. Pig farms. Chlamydia suis was not detected on the
clinically healthy farm C. The pathogen was present on farms A
and B, both dealing with reproductive failure. Chlamydia suis DNA
was found in all (100%) vaginal swabs of farms A and B. Viable C.
suis organisms were present in 7 of 10 (70%) and 11 of 15 (73.3%)
vaginal swabs of farms A and B, respectively. Chlamydial isolates
of farm A and B were examined for the presence of the tet(C) gene.
The tet(C) gene was discovered in two of seven (28.5%) and 6 of 11
(54.5%) C. suis isolates of farms A and B, respectively. Clinical
symptoms disappeared after treatment with enrofloxacin (fluoro-
quinolone, Baytril 5%; Bayer Healthcare), as previously described
[25]. Enrofloxacin was added to the sperm diluter [2 ml (l diluter) 21]
and it was also used to rinse the sow’s reproductive tract (Baytril 5%,
5 ml+95 ml distilled water) immediately before artificial insemina-
tion. Infected sows were re-examined two weeks after treatment and
were negative in both PCR and culture.
4.2. Slaughterhouse employees. Only 12 of 84 (14.3%)
employees voluntarily participated. They provided 12 conjuncti-
val, 12 pharyngeal and 12 stool swabs. Pharyngeal swabs and stool
were all C. suis negative. Two of 12 (16.6%) conjunctival swabs
were positive by the newly developed C. suis real-time PCR,
revealing a Ct-value of 26 and 28, respectively. Real-time PCR
results on all swabs could be confirmed by culture. Culture harvest
of both positively identified C. suis isolates was negative by the
tet(C) PCR. Positive employees worked daily for three years in the
pig gut washing area and for eight years in the animal reception
area, respectively. Clinical signs were absent.
Discussion
Chlamydial infections are treated with tetracyclines. In 1998,
tetracyline resistant (TcR) C. suis strains emerged in the U.S. pig
industry (Iowa and Nebraska), and are currently also known to be
Table 3. Organisms of non-chlamydial origin found in swine and used for specificity testing.
Organisms*
Acinetobacter calcoaceticus Enterobacter sp. Pseudomonas aeruginosa
Bacteroides sp. Enterococcus sp Proteus mirabilis
Bordetella bronchiseptica Escherichia coli Proteus vulgaris
Bordetella pertussis Klebsiella sp. Salmonella enterica subsp. enterica serovar Typhimurium
Bordetella parapertussis Lactobacillus sp. Staphylococcus aureus
Brachyspira sp. Staphylococcus hyicus
Brucella sp. Mycoplasma hyopneumoniae Streptococcus suis
Clostridium sp. Pasteurella multocida Treponema sp.
* Identification of micro-organisms was performed by culture on selective media, biochemical identification and molecular characterization methods like PCR and DNA
sequencing.
doi:10.1371/journal.pone.0096704.t003
Table 4. Organisms of non-chlamydial origin found in humans and used for specificity testing.
Organisms*
Acinetobacter baumannii Klebsiella oxytoca Ruminococcus
Bacteroides sp. Klebsiella pneumoniae Salmonella sp.
Bifidobacterium sp. Lactobacillus sp. Serratia marcescens
Bordetella bronchiseptica Stenotrophomonas sp Shigella sp.
Citrobacter braakii Moraxella catarrhalis Staphylococcus aureus
Citrobacter freundii Morganella morganii Staphylococcus epidermidis
Clostridium sp Mycoplasma pneumoniae Moraxella catarrhalis
Corynebacterium sp. Peptostreptococcus sp. Streptococcus agalactiae
Enterobacter sp. Streptococcus pneumoniae sp. Streptococcus mitis
Enterococcus sp. Propionibacterium sp. Streptococcus nilleri
Escherichia coli Pseudomonas aeruginosa Streptococcus pyogenes
Eubacterium sp. Proteus mirabilis Veillonella sp.
Faecalibacterium sp. Proteus vulgaris
* Identification of micro-organisms was performed by culture on selective media, biochemical identification and molecular characterization methods like PCR and DNA
sequencing.
doi:10.1371/journal.pone.0096704.t004
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prevalent in the Belgian, Cypriote, German, Israeli, Italian and
Swiss pig industry [2,3,9,26,27]. The present study adds an
additional country to the list, as the current study is the first to
discover TcR C. suis strains in the Dutch pig industry. The C. suis
TcR phenotype is manifested through the tetracycline resistance
gene tet(C). Tet(C) is integrated into the chlamydial chromosome
[28], but it is a transposable genetic element, which is also present
in other bacteria such as E. coli.
The international economic consequences of C. suis infections
are not yet fully established, but the financial loss due to severe
reproductive failure and the need for antibiotic treatment
currently worries pig producers all over the world. Moreover,
pig farmers are aware of the existence of TcR C. suis strains and the
risk of importing TcR C. suis contaminated sperm for artificial
insemination [18] (and P. Delava, personal communication 2014).
Furthermore, emergence of TcR chlamydial strains might pose a
potential threat for public health if this species turns out to be a
zoonotic pathogen. Suchland et al. demonstrated in vitro horizontal
transfer of the tetracycline resistance gene among chlamydial
species [29]. Therefore, contact between TcR and TcS Chlamydia
spp. could lead to transfer of the tet(C) gene and the subsequent
phenotype, which could then be propagated and selected for in
patients that are treated with tetracyclines. However, the lack of
evidence of antibiotic resistance leading to treatment failure in
humans, seems to indicate that horizontal transfer of the tet(C)
gene is rather rare. Sandoz and Rockey [30] state that
unsufficiency of the current diagnostic methods, could be the
cause of this lack of evidence.
In this respect, studying the presence of C. suis in humans,
dealing with pigs on a regular basis, is meaningful. Thus, there is
an urgent need for a highly sensitive and specific molecular
diagnostic test to study the epidemiology of C. suis in pigs and to
study a possible transfer of C. suis to humans.
Real-time PCR technology offers the possibility to automatically
combine amplification, specific hybridization and detection in one
single test. It allows specific and sensitive gene quantification with
a minimal contamination risk, as the AmpErase UNG system can
be incorporated in order to prevent post-PCR carry-over of
amplified DNA. The technique has been used successfully to
detect C. pneumoniae [31,32,33,34], C. trachomatis [35], C. felis
[36,37,38], C. pecorum [39], C. psittaci [40], and C. abortus [19].
Although, the high genomic sequence similarity between C. suis
and C. trachomatis made it difficult to design a sensitive C. suis-
specific PCR, the analytical sensitivity of the assay was 10 rDNA
Figure 1. Real-time PCR quantitation of chlamydial S45 genomic DNA (A) and pGemT::CSIC control plasmid (B). The standard curve
data points are the average of 3 replications, standard deviations are shown as error bars. The equations and R2 linearity values resulting from the
linear regression analysis, are shown on the graphs.
doi:10.1371/journal.pone.0096704.g001
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copies/reaction (or two copies/ml). Besides, the C. suis real-time
PCR contains two differentially labeled probes. Albeit differen-
tially labeling is not required for the detection of all C. suis strains,
their use creates the ability to differentiate the two ‘groups’ of C.
suis strains which are distinguished by one single SNP in the target
region.
The C. suis-specific real-time PCR is suitable for diagnosis in
swine as successfully demonstrated in the present case report.
Importantly, the C. suis-specific real-time PCR is also suitable for
human samples, as it distinguishes C. suis from i) the human
pathogens C. trachomatis and C. pneumoniae and ii) the currently
known zoonotic species: C. felis, C. abortus and C. psittaci.
The detection of C. suis DNA as well as viable C. suis in the eyes
of two slaughterhouse employees illustrates the value of this assay
in future investigations on the zoonotic potential of C. suis. Becker
et al. [41] showed intensively raised pigs to be pre-disposed to
chlamydial associated conjunctivitis. Transmission from infected
pig eyes to humans is perhaps not unusual in highly irritant
environments like a slaughterhouse and intensive pig farms. C. suis
positive persons had no clinical complaints and they showed no
disease symptoms. We detected only low amounts of C. suis in the
eyes, and perhaps C. suis only ended up in the eyes by touching
face/eyes with contaminated hands. Possibly, it was just an eye
‘‘contaminant’’ and not a real infection. Perhaps serology would
have clarified this issue. However, employees refused to give blood
during our experiment. Thus, future studies in humans should
include the detection of C. suis-specific antibodies in serum or at
least in conjunctival swabs. None of the participating employees
was infected with C. trachomatis and both C. suis isolates were
tetracycline sensitive. Therefore, further research is needed,
sampling larger human risk populations, to estimate the preva-
lence of C. trachomatis and TcR C. suis strains in people working
with pigs. Besides, the potential of C. suis to cause pathology in the
human eye needs to be examined in more detail, especially since C.
suis is phylogenetically highly related to C. trachomatis, the etiology
of human trachoma, and, as a recent study by Deborah Dean also
found C. suis in the human eye [42].
In conclusion, we designed and validated a C. suis-specific real-
time PCR for use in swine and humans. The assay can be used for
detection and monitoring of C. suis strains in pigs and for
examining their zoonotic potential more extensively. Additionally,
the real-time PCR could be useful for preventing the spread of C.
suis strains, for instance through international trade of boars and
sperm.
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